Cargando…

Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France

Hormonal medication dispensations decreased substantially during lockdown and after in France, especially for emergency contraception, levonorgestrel-releasing intrauterine devices, and ovulation inductors.

Detalles Bibliográficos
Autores principales:	Roland, Noémie, Drouin, Jerôme, Desplas, David, Cuenot, François, Dray-Spira, Rosemary, Weill, Alain, Zureik, Mahmoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Contents
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884086/ https://www.ncbi.nlm.nih.gov/pubmed/33543892 http://dx.doi.org/10.1097/AOG.0000000000004281

Ejemplares similares

Impact of coronavirus disease 2019 on contraception use in France
por: Roland, Noémie, et al.
Publicado: (2023)

Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France
por: Roland, Noémie, et al.
Publicado: (2022)

Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
por: Billioti de Gage, Sophie, et al.
Publicado: (2020)

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people
por: Semenzato, Laura, et al.
Publicado: (2021)

Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines
por: Zureik, Mahmoud, et al.
Publicado: (2023)

Colonoscopy in France during the COVID-19 pandemic
por: Meyer, Antoine, et al.
Publicado: (2021)

Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population‐based study
por: Roland, Noémie, et al.
Publicado: (2022)

Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020
por: Taine, Marion, et al.
Publicado: (2021)

Paediatric outpatient prescriptions in France between 2010 and 2019: A nationwide population-based study: Paediatric outpatient prescriptions in France, 2010 to 2019
por: Taine, Marion, et al.
Publicado: (2021)

Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France
por: Semenzato, Laura, et al.
Publicado: (2022)

Protection of COVID-19 Vaccination Against Hospitalization During the Era of Omicron BA.4 and BA.5 Predominance: A Nationwide Case–Control Study Based on the French National Health Data System
por: Semenzato, Laura, et al.
Publicado: (2023)

Impact de l’épidémie COVID-19 sur l'utilisation des contraceptifs en France en 2020 et jusqu'en avril 2021
por: Roland, N., et al.
Publicado: (2022)

Diminution drastique des mises en route de biomédicaments chez les patients atteints de psoriasis durant la pandémie de COVID-19 en France
por: Penso, Laetitia, et al.
Publicado: (2021)

Traitements du psoriasis et risque d’hospitalisation ou de décès pour COVID-19. Étude de cohorte à propos de 132 6312 patients atteints de psoriasis en France
por: Penso, Laetitia, et al.
Publicado: (2021)

Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients
por: Semenzato, Laura, et al.
Publicado: (2021)

Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France
por: Chaignot, Christophe, et al.
Publicado: (2018)

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines
por: Botton, Jérémie, et al.
Publicado: (2022)

No association of low‐dose aspirin with severe COVID‐19 in France: A cohort of 31.1 million people without cardiovascular disease
por: Botton, Jérémie, et al.
Publicado: (2022)

Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19: A Nationwide Matched Population‐Based Cohort Study
por: Bouillon, Kim, et al.
Publicado: (2022)

Roll-out of HIV pre-exposure prophylaxis use in France: A nationwide observational study from 2016 to 2021
por: Billioti de Gage, Sophie, et al.
Publicado: (2022)

Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
por: Laanani, Moussa, et al.
Publicado: (2023)

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
por: Le Vu, Stéphane, et al.
Publicado: (2022)

Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France
por: Coste, Joël, et al.
Publicado: (2020)

Utilisation des données du Système national des données de santé et/ou PMSI pour des études en lien avec la COVID-19 en France: bilan des publications scientifiques indexées dans Medline
por: Weill, A., et al.
Publicado: (2023)

Pediatric Outpatient Prescriptions in Countries With Advanced Economies in the 21st Century: A Systematic Review
por: Taine, Marion, et al.
Publicado: (2022)

Accessibility of Pharmacist-Prescribed Contraceptives in Utah
por: Magnusson, Brianna M., et al.
Publicado: (2021)

A modified self‐controlled case series method for event‐dependent exposures and high event‐related mortality, with application to COVID‐19 vaccine safety
por: Ghebremichael‐Weldeselassie, Yonas, et al.
Publicado: (2022)

Contraindications to Hormonal Contraception Among Postpartum Women in Texas
por: Coleman-Minahan, Kate, et al.
Publicado: (2021)

Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy
por: Kopp-Kallner, Helena, et al.
Publicado: (2022)

Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France
por: Blotière, Pierre‐Olivier, et al.
Publicado: (2018)

Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study
por: Bouillon, Kim, et al.
Publicado: (2022)

Patterns in Contraceptive Use Among Women of Mexican Origin in the United States and in Mexico
por: Coleman-Minahan, Kate, et al.
Publicado: (2022)

Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France
por: Jabagi, Marie Joelle, et al.
Publicado: (2019)

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System
por: Teal, Stephanie B., et al.
Publicado: (2019)

Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
por: Botton, Jérémie, et al.
Publicado: (2022)

Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception
por: BakenRa, Abena, et al.
Publicado: (2021)

Double Dosing Levonorgestrel-Based Emergency Contraception for Individuals With Obesity: A Randomized Controlled Trial
por: Edelman, Alison B., et al.
Publicado: (2022)

8Association entre les vaccins COVID-19 à ARN messager et la survenue de myocardite et péricardite chez les personnes de 12 à 50 ans en France
por: Vu, S. Le, et al.
Publicado: (2022)

Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster
por: Jabagi, Marie-Joelle, et al.
Publicado: (2023)

Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children
por: Lassalle, Marion, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ha30ktqosc0g9kf41i5f1cdve